Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Immunohistochemistry using clone VE1 is an economic, specific and sensitive method for detecting the presence of BRAFV600E mutations in melanoma].

Annales de dermatologie et de venereologie - 1 Mar 2018

Etienne M, Oca F, Prunier-Mirebeau D, Croué A, Martin L

Abstract excerpt

BACKGROUND: Determination of BRAF mutation status is mandatory in the management of patients with inoperable stage IIIC or stage IV melanoma. Currently, molecular biology (MB) has been validated for detecting the presence of BRAF mutations. OBJECTIVE: To compare the sensitivity, specificity and cost of immunohistochemistry (IHC) (clone VE1) versus BM methods (qPCR and Sanger sequencing). PATIENTS AND METHODS: All...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clone Cells
Share to France

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Molecular Biology

Share to Neoplasm Staging

Share to Predictive Value of Tests

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Source

Identifiers

PMID: 29221650
DOI: 10.1016/j.annder.2017.10.011

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Immunohistochemistry using clone VE1 is an economic, specific and sensitive method for detecting the presence of BRAFV600E mutations in melanoma].PMID 29221650Read ↗

A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma.Semantic proximity Read ↗

[Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma].Semantic proximity Read ↗

Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.Semantic proximity Read ↗

A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.Semantic proximity Read ↗

Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.Semantic proximity Read ↗

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.Semantic proximity Read ↗

BRAF V600E mutation-specific antibody: A review.Semantic proximity Read ↗

Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.Semantic proximity Read ↗

BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods.Semantic proximity Read ↗

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?Semantic proximity Read ↗

Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis.Semantic proximity Read ↗

Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.